Provided by Tiger Fintech (Singapore) Pte. Ltd.

HENGRUI PHARMA

70.800
-0.300-0.42%
Volume:2.87M
Turnover:205.29M
Market Cap:469.90B
PE:64.67
High:72.600
Open:70.900
Low:70.700
Close:71.100
52wk High:95.200
52wk Low:52.500
Shares:6.64B
HK Float Shares:258.00M
Volume Ratio:0.77
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.095
ROE:14.34%
ROA:8.37%
PB:7.21
PE(LYR):64.67
PS:13.85

Loading ...

Hengrui Medicine Gets Nod to Conduct Clinical Trials on Allergy Drug

MT Newswires Live
·
Sep 24

HENGRUI PHARMA (01276) Spent RMB 89.94 Million to Repurchase 1.298 Million A-Shares on September 23

Stock News
·
Sep 23

HENGRUI PHARMA (01276): New Indication Application for Adebrelimab Injection Accepted by National Medical Products Administration

Stock News
·
Sep 23

HENGRUI PHARMA (01276): HRS-3095 Tablets Approved for Clinical Trials

Stock News
·
Sep 23

AH Share Premium Statistics | September 22

Stock News
·
Sep 22

HENGRUI PHARMA (01276) Repurchases 656,000 A-Shares for RMB 45.75 Million on September 19

Stock News
·
Sep 22

AH Stock Premium Statistics | September 19

Stock News
·
Sep 19

China Grants Hengrui's Hepatitis-B Injection Breakthrough Therapy Designation; Hong Kong Shares Rise 5%

MT Newswires Live
·
Sep 18

AH Statistics | September 17

Stock News
·
Sep 17

Hengrui Medicine Gets Clinical Trial Approvals for Three Drugs

MT Newswires Live
·
Sep 17

Hong Kong Stock Morning Brief | Nine Departments Issue Policies to Expand Service Consumption, Spot Gold Breaks Through $3,700 to Set New Record High

Stock News
·
Sep 17

Jiangsu Hengrui Pharmaceuticals Co.,Ltd. (600276.SH): Clinical Trial Approved for SHR-1826 Injection in Combination with Other Drugs

Stock News
·
Sep 16

AH Stock Statistics | September 15

Stock News
·
Sep 15

UBS Group Increases Stake in HENGRUI PHARMA (01276) by 204,400 Shares at Approximately HK$85.88 Per Share

Stock News
·
Sep 12

HENGRUI PHARMA (01276) Repurchases 235,000 A-Shares for RMB 15.93 Million on September 11

Stock News
·
Sep 11

AH Stock Statistics | September 10

Stock News
·
Sep 10

Tianfeng Securities: Weight Loss Market Continues to Expand, MNC Pipeline Expectations Gap May Accelerate Domestic Molecular BD Landing

Stock News
·
Sep 10

Nomura Adjusts Jiangsu Hengrui Pharmaceuticals' Price Target to HK$94.54 From HK$80.57, Keeps at Buy

MT Newswires Live
·
Sep 08

AH Stock Statistics | September 8

Stock News
·
Sep 08

AH Statistics | September 5

Stock News
·
Sep 05